Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association-Reference-Cited by-同舟云学术

Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association

Published:2011-06-30 Issue:7 Volume:96 Page:942-947
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Shaw B. E.,Confer D. L.,Hwang W. Y.,Pamphilon D. H.,Pulsipher M. A.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Biosimilar Filgrastim with Innovator Fligrastim for Peripheral Blood Stem Cells Mobilization, Collection of CD34+ Stem Cells, and Engraftment in Patients Undergoing Autologous and Allogeneic Stem Cell Transplantation: A Single-Center Experience;Annals of Transplantation;2023-02-20

2. The effect of granulocyte colony stimulating factor on genotoxicity in allogeneic peripheral blood stem cell transplantation donors: a prospective case-control study;The Turkish Journal of Pediatrics;2023

3. Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant;Bone Marrow Transplantation;2021-11-30

4. Preclinical immunogenicity testing using anti-drug antibody analysis of GX-G3, Fc-fused recombinant human granulocyte colony-stimulating factor, in rat and monkey models;Scientific Reports;2021-06-07

Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients with Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation

;Journal of Blood Medicine;2020-04